INMED PHARMACEUTICALS (IMLFF)
IMLFF moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How IMLFF actually reacts to news — the realized, point-in-time move the market made, measured across 148 labeled events over its full measured history with zero look-ahead.
IMLFF’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.03% | 51% | 145 |
| 30-min | 0.00% | 48% | 147 |
| 60-min | 0.00% | 47% | 147 |
| to close | 0.00% | 49% | 147 |
| Middle 50% of IMLFF reactions | -2.23% to +3.50% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 148 |
Half of all INMED PHARMACEUTICALS news events land between -2.23% and +3.50% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when IMLFF moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to IMLFF's baseline. Nothing else.
Recent IMLFF events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form EFFECT InMed Pharmaceuticals | SEC filing · Form EFFECT | SEC EDGAR | +1.84% | -2.21% | |
| Form S-4/A InMed Pharmaceuticals | SEC filing · Form S-4 | SEC EDGAR | +0.37% | +0.74% | |
| Form 8-K InMed Pharmaceuticals For: Sep 16 | SEC filing · Form 8-K | SEC EDGAR | — | +1.47% | |
| Form 10-K InMed Pharmaceuticals For: Jun 30 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +0.00% | |
| Form S-4/A InMed Pharmaceuticals | SEC filing · Form S-4 | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K InMed Pharmaceuticals For: Jul 22 | SEC filing · Form 8-K | SEC EDGAR | -2.32% | +12.12% | |
| Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline | Press release | PR Newswire | +0.93% | -22.07% | |
| Form 8-K InMed Pharmaceuticals For: Jul 06 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.27% | |
| Form S-4 InMed Pharmaceuticals | SEC filing · Form S-4 | SEC EDGAR | +0.00% | +3.21% | |
| Form 8-K InMed Pharmaceuticals For: Jun 03 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.34% | |
| Are RAMP, INM, D, NEE Obtaining Fair Deals for their Shareholders? | Press release | PR Newswire | -1.78% | -4.85% | |
| Form 8-K InMed Pharmaceuticals For: May 18 | SEC filing · Form 8-K | SEC EDGAR | -11.86% | -9.61% | |
| Form 8-K InMed Pharmaceuticals For: May 19 | SEC filing · Form 8-K | SEC EDGAR | +3.91% | +14.66% | |
| INM Stock Alert: Halper Sadeh LLC is Investigating Whether InMed Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders | Press release | Business Wire | -4.81% | -0.89% | |
| InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies | Press release | PR Newswire | -11.86% | -9.61% | |
| SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of InMed Pharmaceuticals, Inc. (Nasdaq – INM) | Press release | GlobeNewswire | -2.35% | +8.05% | |
| Form 8-K InMed Pharmaceuticals For: May 06 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.60% | |
| Form 10-Q InMed Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -4.60% | |
| Form 8-K InMed Pharmaceuticals For: Apr 21 | SEC filing · Form 8-K | SEC EDGAR | — | -4.37% | |
| Form 8-K InMed Pharmaceuticals For: Apr 03 | SEC filing · Form 8-K | SEC EDGAR | — | +6.88% | |
| Form EFFECT InMed Pharmaceuticals | SEC filing · Form EFFECT | SEC EDGAR | +2.96% | +12.16% | |
| Form 8-K InMed Pharmaceuticals For: Mar 27 | SEC filing · Form 8-K | SEC EDGAR | +2.96% | +12.16% | |
| Form 8-K InMed Pharmaceuticals For: Mar 23 | SEC filing · Form 8-K | SEC EDGAR | -9.30% | -8.31% | |
| Form S-3 InMed Pharmaceuticals | SEC filing · Form S-3 | SEC EDGAR | -9.30% | -8.31% | |
| Form 8-K InMed Pharmaceuticals For: Mar 09 | SEC filing · Form 8-K | SEC EDGAR | -2.39% | -1.76% | |
| Form 8-K InMed Pharmaceuticals For: Mar 04 | SEC filing · Form 8-K | SEC EDGAR | -2.39% | -1.76% | |
| Form 8-K InMed Pharmaceuticals For: Feb 11 | SEC filing · Form 8-K | SEC EDGAR | -4.96% | -8.05% | |
| Form 10-Q InMed Pharmaceuticals For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | -4.96% | -8.05% | |
| Form 8-K InMed Pharmaceuticals For: Dec 17 | SEC filing · Form 8-K | SEC EDGAR | -0.39% | +0.00% | |
| Form 8-K InMed Pharmaceuticals For: Dec 12 | SEC filing · Form 8-K | SEC EDGAR | -2.88% | -13.67% | |
| Life Sciences Virtual Investor Forum Agenda Announced for December 11th | Press release | GlobeNewswire | -0.75% | -2.24% | |
| Form S-8 InMed Pharmaceuticals | SEC filing · Form S-8 | SEC EDGAR | -0.75% | -2.24% | |
| Form 8-K InMed Pharmaceuticals For: Nov 18 | SEC filing · Form 8-K | SEC EDGAR | -1.43% | -10.07% | |
| Form 10-Q InMed Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.27% | -5.33% | |
| Form DEF 14A InMed Pharmaceuticals For: Dec 17 | SEC filing · Form DEF | SEC EDGAR | -1.40% | -2.12% | |
| Form DEFA14A InMed Pharmaceuticals | SEC filing · Form DEFA14A | SEC EDGAR | -1.40% | -2.12% | |
| Form 10-K/A InMed Pharmaceuticals For: Jun 30 | SEC filing · Form 10-K | SEC EDGAR | +0.49% | -0.97% | |
| Form PRE 14A InMed Pharmaceuticals For: Oct 24 | SEC filing · Form PRE | SEC EDGAR | +0.49% | -0.97% | |
| Form 8-K InMed Pharmaceuticals For: Oct 14 | SEC filing · Form 8-K | SEC EDGAR | +1.56% | +0.96% | |
| Form 8-K InMed Pharmaceuticals For: Oct 09 | SEC filing · Form 8-K | SEC EDGAR | +0.94% | +3.29% | |
| Form 8-K InMed Pharmaceuticals For: Oct 10 | SEC filing · Form 8-K | SEC EDGAR | +0.94% | +3.29% | |
| Form 10-K InMed Pharmaceuticals For: Jun 30 | SEC filing · Form 10-K | SEC EDGAR | -0.14% | -3.17% | |
| Form 8-K InMed Pharmaceuticals For: Sep 23 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| InMed to Present at the Life Sciences Virtual Investor Forum September 18th, 2025 | Press release | GlobeNewswire | +0.00% | -0.21% | |
| Form 8-K InMed Pharmaceuticals For: Sep 05 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.38% | |
| Form EFFECT InMed Pharmaceuticals | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | -0.84% | |
| Form S-1/A InMed Pharmaceuticals | SEC filing · Form S-1 | SEC EDGAR | -0.83% | -0.83% | |
| Form 8-K InMed Pharmaceuticals For: Jul 28 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form S-1 InMed Pharmaceuticals | SEC filing · Form S-1 | SEC EDGAR | +1.06% | -0.35% | |
| Form 8-K InMed Pharmaceuticals For: Jun 24 | SEC filing · Form 8-K | SEC EDGAR | -0.32% | +0.00% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the IMLFF section they belong to.
Where else IMLFF is measured.
IMLFF earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Sol-Gel Technologies Ltd. - Ordinary Shares (SLGL) | 149 | 0.00% | 42% |
| BioLineRx Ltd. - American Depositary Shares (BLRX) | 148 | -0.82% | 40% |
| Akari Therapeutics Plc - American Depositary Shares (AKTX) | 146 | 0.00% | 45% |
| BeyondSpring, Inc. - Ordinary Shares (BYSI) | 146 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is INMED PHARMACEUTICALS's median reaction calculated?
Every labeled IMLFF news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 148 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 48% of IMLFF's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does IMLFF's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.